Zibo, Shandong, China INTCO Medical is the famous Corporate Investor, which was founded in 2009. The main department of described Corporate Investor is located in the Zibo. The company was established in Asia in China.
Besides, a startup needs to be aged 2-3 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. We can highlight the next thriving fund investment areas, such as Service Industry, Medical Device. Among the most popular portfolio startups of the fund, we may highlight LyncMed.
The common things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2018. The fund is constantly included in less than 2 deals per year.
The usual cause for the fund is to invest in rounds with 3 partakers. Despite the INTCO Medical, startups are often financed by Yunqi Partners. The meaningful sponsors for the fund in investment in the same round are Yunqi Partners, Chunxiao Capital. In the next rounds fund is usually obtained by Yunqi Partners, VisionMax Health Fund, InnoVen Capital.
Related Funds
| Fund Name | Location |
| Cyhawk Ventures | Israel, Tel Aviv, Tel Aviv District |
| Georgia State University | Atlanta, Georgia, United States |
| Hai Quan Fund | Beijing, Beijing, China |
| HD Capital | - |
| Hongfund Financial | China, Shanghai |
| Hudson River Angels | - |
| IPGL | England, London, United Kingdom |
| Jilin University Alumni Fund | - |
| Kairos Angels | - |
| Kangmei Pharmaceutical | China, Guangdong Province, Huizhou |
| Macomb Community College | Michigan, United States, Warren |
| MassChallenge Switzerland | Renens, Switzerland, Vaud |
| Oracle Investment Management Inc. | Connecticut, Greenwich, United States |
| Social and Sustainable Capital | England, London, United Kingdom |
| Steel City Capital Funding | - |
| The Hina Group | California, San Francisco, United States |
| Van Wickle Ventures | Providence, Rhode Island, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
LyncMed | $17M | 02 Apr 2018 | Beijing |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
LyncMed | $17M | 02 Apr 2018 | Beijing |
